1. Dickens C, Cherrington A, McGowan L.
Depression and health-related quality of life in
people with coronary heart disease: A
systematic review. Eur J Cardiovasc
Nurs. 2012;11:265–275.
2. Zwadlo C, Meyer GP, Schieffer B, WesthoffBleck M. Anomalous intramural course of
coronary arteries in congenital heart diseasethree case reports and review of the
literature. Congenit Heart Dis. 2012;7:139–144.
3. Mehra M, Somohano T, Choi M. Mandibular
fibular graft reconstruction with CAD/CAM
technology: A clinical report and literature
review. J Prosthet Dent. 2016;115:123–128.
4. WHO Fact sheet N°310. updated July 2013
http://www.who.int/mediacentre/factsheets/fs31
0/en/index.html.
5. de Hoog VC, Timmers L, Schoneveld AH,
Wang JW, van de Weg SM, Sze SK, et al.
Serum extracellular vesicle protein levels are
associated with acute coronary syndrome. Eur
Heart J Acute Cardiovasc Care 2013;2(1):53–
60.
6. Reichlin T, Hochholzer W, Bassetti S, Steuer S,
Stelzig C, Hartwiger S, et al. Early diagnosis
ofmyocardial infarction with sensitive cardiac
troponin assays. N Engl JMed 2009;361(9):858–
67
7. Dharnidharka VR, Kwon C, Stevens G. Serum
cystatin C is superior to serum creatinine as a
marker of kidney function: a meta-analysis. Am
J Kidney Dis 2002; 40(2): 221-6
8. Grubb A, Bjork J, Lindstrom V, et al. A cystatin
C-based formula without anthropometric
variables estimates glomerular filtration rate
better than creatinine clearance using the
Cockcroft-Gault formula. Scand J Clin Lab
Invest 2005; 65(2): 153-62.
9. Grubb A, Nyman U, Bjork J, et al. Simple
cystatin C-based prediction equations for
glomerular filtration rate compared with the
modification of diet in renal disease prediction
equation for adults and the Schwartz and the
Counahan-Barratt prediction equations for
children. Clin Chem 2005; 51(8): 1420-31
10. Ix JH, Shlipak MG, Chertow GM, et al.
Association of cystatin C with mortality,
cardiovascular events, and incident heart failure
among persons with coronary heart disease: data
from the Heart and Soul Study. Circulation
2007; 115(2): 173-9
11. Kestenbaum B, Rudser KD, de Boer IH, et al.
Differences in kidney function and incident
hypertension: the multi-ethnic study of
atherosclerosis. Ann Intern Med 2008; 148(7):
501-8.
12. Sarnak MJ, Katz R, Stehman-Breen CO, et al.
Cystatin C concentration as a risk factor for
heart failure in older adults. Ann Intern Med
2005; 142(7): 497-505.
13. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin
C and the risk of death and cardiovascular
events among elderly persons. N Engl J Med
2005; 352(20): 2049-60 doi:
10.1056/NEJMoa043161published Online First:
Epub Date.
14. Taglieri N, Fernandez-Berges DJ, Koenig W, et
al. Plasma cystatin C for prediction of 1-year
cardiac events in Mediterranean patients with
non-ST elevation acute coronary syndrome.
Atherosclerosis 2010; 209(1): 300-5.
15. Koc M, Batur MK, Karaarslan O, Abali G.
Clinical utility of serum cystatin C in predicting
coronary artery disease. Cardiol J
2010;17(4):374–80.
16. Ristiniemi N, Lund J, Tertti R, Christensson A,
Ilva T, Porela P, et al. Cystatin C as a predictor
of all-cause mortality and myocardial infarction
in patients with non-STelevation acute coronary
syndrome. Clin Biochem 2012;45(7–8):535–40.
17. Silva D, Cortez-Dias N, Jorge C, Marques JS,
Carrilho-Ferreira P, Magalhães A, et al. Cystatin
C as prognostic biomarker in ST-segment
elevation acute myocardial infarction. Am J
Cardiol 2012;109(10):1431–8.
18. Yan L1, Ding S2, Gu B1,2, Ma P1,2. Clinical
application of simultaneous detection of cystatin
C, cathepsin S, and IL-1 in classification
of coronary artery disease. J Biomed Res. 2017
Jul 13;31(4):315-320.
19. Sugiyama H1, Miyoshi T2, Osawa K1, Miki
T1, Koide Y1, Nakamura K1, Morita H3, Ito
H1. Serum cystatin C levels are associated
with coronary artery calcification in women
without chronic kidney disease. J Cardiol. 2017
Dec;70(6):559-564.
20. Zhang J1, Wu X2, Gao P3, Yan P4.Correlations
of serum cystatin C and glomerular filtration
rate with vascular lesions and severity in
acute coronary syndrome. BMC Cardiovasc
Disord. 2017 Jan 31;17(1):47.
21. Wang Y1, Su X2, Zhang W2, Yang W2, Wang
Y2, He Y3. Correlation between serum cystatin
C level and elderly hypertensive patients
combined coronaryheart disease. Int J Clin Exp
Med. 2015 Apr 15;8(4):6287-90. eCollection
2015.
22. Negrusz-Kawecka M1, Poręba R2, Hulok
A1, Sciborski K1, Marczak J3, Bańkowski T4.
Evaluation of the significance of cystatin
C levels in patients suffering from coronary
artery disease. Adv Clin Exp Med. 2014 JulAug;23(4):551-8.
23. Wang GN1, Sun K1, Hu DL1, Wu HH1, Wang
XZ2, Zhang JS3. Serum cystatin C levels are
associated with coronary artery disease and its
severity. Clin Biochem. 2014 Nov;47(16-
17):176-81.
24. Abdallah E, Waked E, Al-Helal B, Asad R,
Nabil M, Harba T. Novel troponin-like
biomarkers of acute kidney injury. Saudi J
Kidney Dis Transpl. 2013;24:1111–24.
25. Longenecker CT, Hileman CO, Funderburg NT,
McComsey GA. Rosuvastatin preserves renal
function and lowers cystatin C in HIV-infected
subjects on antiretroviral therapy: the SATURNHIV trial. Clin Infect Dis. 2014;59:1148–56.
26. Ganda A, Magnusson M, Yvan-Charvet L,
Hedblad B, Engström G, Ai D, et al. Mildrenal
dysfunction and metabolites tied to low HDL
cholesterol are associated with monocytosis and
atherosclerosis. Circulation. 2013;127:988–96.
27. Ge C, Ren F, Lu S, Ji F, Chen X, Wu X. Clinical
prognostic significance of plasma cystatin C
levels among patients with acute coronary
syndrome. Clin Cardiol. 2009;32:644–8.
28. 21. Negrusz-Kawecka M, Poręba R, Hulok A,
Sciborski K, Marczak J, Bańkowski T.
Evaluation of the significance of cystatin C
levels in patients suffering from coronary artery
disease. Adv Clin Exp Med. 2014;23:551–8.
29. Vakili H1, Mohamadian A2, Naderian
M3, Khaheshi I4. Cystatin C may not be a
precious predictor for coronary artery
disease and its severity: an area of uncertainty.
Acta Biomed. 2018 Jun 7;89(2):209-213.
30. Svensson-Färbom P1, Almgren P2, Hedblad
B2, Engström G2, Persson M3, Christensson
A4, Melander O3. Cystatin C Is Not Causally
Related to Coronary Artery Disease. PLoS
One. 2015 Jun 9;10(6):e0129269.
31. Shi GP, Sukhova GK, Grubb A, Ducharme A,
Rhode LH, Lee RT, et al. Cystatin C deficiency
in human atheroscler-osis and aortic
aneurysms. J Chin Invest. 1999;104:1191–7.
)